RANTES/CCL5, Human

Product Information
Primary Accession	P13501
Sequence	Ser²⁴-Ser⁹¹
Purity	> 95% as analyzed by SDS-PAGE and HPLC.
Endotoxin Level	< 0.2 EU/ µg, determined by LAL method.

Additional Information
Gene ID	6352
Other Names	C-C motif chemokine 5, EoCP, Eosinophil chemotactic cytokine, SIS-delta, Small-inducible cytokine A5, T cell-specific protein P228, TCP228, T-cell-specific protein RANTES, RANTES(3-68), RANTES(4-68), CCL5, D17S136E, SCYA5
Target Background	RANTES/CCL5, Human

For Research Use Only. Not For Use In Diagnostic Procedures.

Protein Information
Name	CCL5
Synonyms	D17S136E, SCYA5
Function	Chemoattractant for blood monocytes, memory T-helper cells and eosinophils. Causes the release of histamine from basophils and activates eosinophils. May activate several chemokine receptors including CCR1, CCR3, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant RANTES protein induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form RANTES(3-68) acts as a natural chemotaxis inhibitor and is a more potent inhibitor of HIV-1-infection. The second processed form RANTES(4-68) exhibits reduced chemotactic and HIV-suppressive activity compared with RANTES(1-68) and RANTES(3-68) (PubMed:1380064, PubMed:15923218, PubMed:16791620, PubMed:8525373, PubMed:9516414). May also be an agonist of the G protein-coupled receptor GPR75, stimulating inositol trisphosphate production and calcium mobilization through its activation. Together with GPR75, may play a role in neuron survival through activation of a downstream signaling pathway involving the PI3, Akt and MAP kinases. By activating GPR75 may also play a role in insulin secretion by islet cells (PubMed:23979485).
Cellular Location	Secreted.
Tissue Location	Expressed in the follicular fluid (at protein level). T-cell and macrophage specific.